Hypercortisolism control pivotal to successful outcomes in patients with bilateral adrenal tumors
Regardless of treatment modality, effective control of hypercortisolism in patients with bilateral adrenal tumors is key to achieving favorable cardiovascular outcomes, suggests a data analysis of the ENSAT trial.